- Corporate Officers - F
- Fromkin Andrew J.
Insider Trading History of Fromkin Andrew J.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fromkin Andrew J. since 2006.
This trader's CIK number is 1341896.
At the time of last reporting, Fromkin Andrew J. was the Director of Immunovant, Inc.. (stock ticker symbol IMVT).
Also see all insider trading activities at Immunovant, Inc..
Note that in the past
Fromkin Andrew J. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Immunovant, Inc. (IMVT) by Fromkin Andrew J.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | IMVT | 0 | $0 | 8,000 | $157,920 | 0 | $0 |
| 2023 | IMVT | 0 | $0 | 12,350 | $490,085 | 0 | $0 |
| 2021 | IMVT | 5,500 | $43,450 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Clinical Data Inc (CLDA) by Fromkin Andrew J.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | CLDA | 2,000 | $19,128 | 0 | $0 | 2,000 | $30,000 |
| 2007 | CLDA | 3,080 | $74,924 | 0 | $0 | 0 | $0 |
| 2006 | CLDA | 650 | $10,836 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Fromkin Andrew J.:
1. Immunovant, Inc. (IMVT)
2. Clinical Data Inc (CLDA)
Table 1. Insider trading of Immunovant, Inc. (IMVT) by Fromkin Andrew J.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-07 | IMVT | Sale | 8,000 | 19.74 | 157,920 |
| 2023-12-01 | IMVT | Sale | 12,350 | 39.68 | 490,085 |
| 2021-08-10 | IMVT | Buy | 5,500 | 7.90 | 43,450 |
Table 2. Insider trading of Clinical Data Inc (CLDA) by Fromkin Andrew J.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-11-12 | CLDA | Buy | 2,000 | 9.56 | 19,128 |
| 2008-09-02 | CLDA | Option Ex | 2,000 | 15.00 | 30,000 |
| 2007-12-12 | CLDA | Buy | 1,880 | 22.81 | 42,890 |
| 2007-09-06 | CLDA | Buy | 1,200 | 26.70 | 32,034 |
| 2006-12-11 | CLDA | Buy | 650 | 16.67 | 10,836 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Fromkin Andrew J.
(Director of Immunovant, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.